Earnings Call · Q2 FY2023·2023-08-03

Q2 23EPS +12.14%·Rev n/aQ1 23EPS +100.00%*·Rev n/aQ4 22EPS -21.52%·Rev n/aQ3 22EPS -18.65%·Rev n/a⚠ consensus missing

Moderna, Inc. MRNA

Lavina Talukdar — Head of Investor Relations

Stéphane Bancel

Stephen Hoge — President

Arpa Garay — Chief Commercial Officer

Jamey Mock — Chief Financial Officer

−0.2%1d on move date0.0% vs SPY3d−8.2%5d−7.6%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MRNA calls or request research access.

More MRNA calls Browse calls Request research access